| Overall N = 359 | Survivals N = 280 | Deaths N = 53 | P value |
---|---|---|---|---|
Age, Years, median (IQR) | 39 (31,52) | 39 (29,48) | 49 (35,63) | < 0.001 |
Male gender N (%) | 325 (90.53%) | 254 (90.71%) | 48 (90.57%) | 1.000 |
On cART N (%) | 98 (27.30%) | 83 (29.64%) | 8 (15.09%) | 0.029 |
Diagnostic delaya N (%) | 153 (42.60%) | 106 (37.86%) | 36 (67.92%) | < 0.001 |
Extrapulmonary Involvement | 49 (13.65%) | 35 (12.50%) | 12 (22.64%) | 0.052 |
Clinical symptoms | ||||
 Fever (> 39 °C) N (%) | 263 (73.26%) | 207 (73.93%) | 32 (60.38%) | 0.044 |
 Cough N (%) | 181 (50.42%) | 144 (51.43%) | 28 (52.83%) | 0.851 |
 Expectoration N (%) | 82 (22.84%) | 61 (21.79%) | 17 (32.08%) | 0.105 |
 Anorexia N (%) | 81 (22.56%) | 60 (21.45%) | 13 (24.53%) | 0.617 |
 Dyspnea N (%) | 69 (19.22%) | 49 (17.50%) | 16 (30.19%) | 0.033 |
Complications | ||||
 Bacterial pneumonia N (%) | 32 (8.91%) | 18 (6.43%) | 14 (26.42%) | < 0.001 |
 HBV/HCV co-infection N (%) | 25 (6.96%) | 19 (6.79%) | 6 (11.32%) | 0.387 |
 Syphilis N (%) | 33 (9.19%) | 30 (10.71%) | 1 (1.89%) | 0.077 |
 Diabetes N (%) | 14 (3.90%) | 11 (3.93%) | 2 (3.77%) | 1.000 |
 Hypertension N (%) | 12 (3.345%) | 9 (3.21%) | 2 (3.77%) | 1.000 |
Laboratory examination | ||||
 Sputum smear positive N (%) | 156 (43.45%) | 126 (45.00%) | 21 (39.62%) | 0.470 |
 Sputum culture positive N (%) | 180 (50.14%) | 141 (50.36%) | 23 (43.40%) | 0.353 |
 T-spot. TB test positive N (%) | 227 (63.23%) | 181 (64.64%) | 30 (56.60%) | 0.265 |
 HIV RNA lg copies/ml median (IQR) | 5.17 (3.91,5.66) | 5.14 (3.83,5.65) | 5.32 (4.61,5.79) | 0.354 |
 CD4+ T cell/mm3 median (IQR) | 51 (23 116) | 55 (27 122) | 24.5 (10,86) | 0.001 |
Manifestation of lung CT scan | ||||
 Extensive pulmonary lesionb N (%) | 218 (60.72%) | 160 (57.14%) | 41 (77.36%) | 0.006 |
 Pulmonary cavity N (%) | 36 (10.03%) | 25 (8.93%) | 9 (16.98%) | 0.076 |
 Pulmonary atelectasis N (%) | 31 (8.64%) | 20 (7.14%) | 9 (16.98%) | 0.039 |